Home › Funds › HARBOURVEST PARTNERS LLC › IPSC
HARBOURVEST PARTNERS LLC position in IPSC
CENTURY THERAPEUTICS INC · Health Care
HARBOURVEST PARTNERS LLC reported holding 29,018 shares of IPSC (CENTURY THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$71K, representing 0.04% of its reported portfolio and ranking #6 among its reported holdings. HARBOURVEST PARTNERS LLC has disclosed IPSC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How HARBOURVEST PARTNERS LLC's IPSC position evolved
HARBOURVEST PARTNERS LLC first disclosed a stake in IPSC in Q3 2023 at 29,018 shares (US$58K). The position peaked in Q1 2024 at 29,018 shares, worth US$121K. Across 12 filings, HARBOURVEST PARTNERS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 29,018 shares valued at US$71K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 29.02K | $58.04K | New |
| Q4 2023 | 29.02K | $96.34K | Hold |
| Q1 2024 | 29.02K | $121.30K | Hold |
| Q2 2024 | 29.02K | $74.00K | Hold |
| Q3 2024 | 29.02K | $49.62K | Hold |
| Q4 2024 | 29.02K | $29.31K | Hold |
| Q1 2025 | 29.02K | $13.81K | Hold |
| Q2 2025 | 29.02K | $16.21K | Hold |
| Q3 2025 | 29.02K | $14.45K | Hold |
| Q4 2025 | 29.02K | $28.87K | Hold |
| Q1 2026 | 29.02K | $65.58K | Hold |
| Q2 2026 | 29.02K | $71.09K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IPSC and 13F data
IPSC (CENTURY THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in IPSC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$43.5M), TCG Crossover Management, LLC (US$43.4M), Versant Venture Management, LLC (US$29.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IPSC
- RA CAPITAL MANAGEMENT, L.P. 17.75M sh · $43.50M · Q2 2026
- TCG Crossover Management, LLC 17.75M sh · $43.40M · Q2 2026
- Versant Venture Management, LLC 12.17M sh · $29.81M · Q2 2026
- Commodore Capital LP 8.70M sh · $21.30M · Q2 2026
- Venrock Adviser, LLC 8.70M sh · $21.30M · Q2 2026
- Seven Fleet Capital Management LP 4.35M sh · $10.65M · Q2 2026
- Trails Edge Capital Partners, LP 4.13M sh · $10.13M · Q2 2026
- Spruce Street Capital LP 4.06M sh · $9.94M · Q2 2026
- DAFNA Capital Management LLC 2.40M sh · $5.88M · Q2 2026
- STEMPOINT CAPITAL LP 2.15M sh · $5.26M · Q2 2026
- DV Trading LLC 1.40M sh · $3.43M · Q2 2026
- Casdin Capital 1.23M sh · $3.01M · Q2 2026
More on HARBOURVEST PARTNERS LLC
FAQ
How long has HARBOURVEST PARTNERS LLC held IPSC?
HARBOURVEST PARTNERS LLC has disclosed IPSC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is HARBOURVEST PARTNERS LLC's current position in IPSC?
As of Q2 2026, HARBOURVEST PARTNERS LLC holds 29.02K shares of IPSC (CENTURY THERAPEUTICS INC), valued at $71.09K, representing 0.04% of its reported portfolio and ranking #6.
Has HARBOURVEST PARTNERS LLC been buying or selling IPSC?
In the latest 13F filing (Q2 2026), HARBOURVEST PARTNERS LLC held unchanged its position in IPSC. The position peaked in Q1 2024 at 29.02K shares.
Which other funds hold IPSC?
Other major institutional holders of IPSC include RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, Versant Venture Management, LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.